Alerts will be sent to your verified email
Verify Email
AUROLAB
|
Auro Laboratories
|
Quest Laboratories
|
Sotac Pharmaceutical
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.83 % | 27.48 % | -2.41 % |
|
5yr average Equity Multiplier
|
1.84 | 2.66 | 5.52 |
|
5yr Average Asset Turnover Ratio
|
0.8 | 1.38 | 1.27 |
|
5yr Avg Net Profit Margin
|
9.49 % | 8.5 % | 3.04 % |
|
Price to Book
|
3.3 | 1.75 | 2.69 |
|
P/E
|
135.79 | 10.55 | 17.76 |
|
5yr Avg Cash Conversion Cycle
|
80.24 Days | 100.68 Days | 57.86 Days |
|
Inventory Days
|
56.39 Days | 35.64 Days | 44.94 Days |
|
Days Receivable
|
214.37 Days | 95.62 Days | 113.65 Days |
|
Days Payable
|
115.48 Days | 124.41 Days | 123.13 Days |
|
5yr Average Interest Coverage Ratio
|
10.53 | 15.83 | 3.95 |
|
5yr Avg ROCE
|
16.02 % | 36.4 % | 21.68 % |
|
5yr Avg Operating Profit Margin
|
15.11 % | 12.5 % | 8.59 % |
|
5 yr average Debt to Equity
|
0.48 | 0.33 | 2.1 |
|
5yr CAGR Net Profit
|
-23.84 % | 83.07 % | n/a |
|
5yr Average Return on Assets
|
7.53 % | 10.79 % | 3.18 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.18 % | 66.78 % | 72.85 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.09 % | 0.95 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Auro Laboratories
|
Quest Laboratories
|
Sotac Pharmaceutical
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|